This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Syntroleum Vigorously Defends Bio-Synfining (R) Technology Against Neste Allegations

Stocks in this article: SYNM

TULSA, Okla., Dec. 21, 2012 (GLOBE NEWSWIRE) -- On December 20, 2012, Syntroleum Corporation (Nasdaq:SYNM) was sued for alleged patent infringement in the District of Delaware by Neste Oil Oyj regarding U.S. Patent No. 8,212,094. The '094 patent covers similar subject matter and shares a common inventor with prior Neste patents (U.S. Patent Nos. 7,279,018 and 8,187,344), as they are directed to processes for making, or compositions of, diesel fuel or diesel range hydrocarbons. Syntroleum has not infringed any of Neste's alleged patent rights and Syntroleum will continue to vigorously defend against Neste's allegations. The '094 patent, like the '018 and '344 patents, adds nothing new to the field of diesel fuels or methods for making same. All claims of Neste's prior '018 patent were invalidated following a March 22, 2012 decision by the USPTO Board of Patent Appeals and Interferences finding that "the evidence of record as a whole supports the Examiner's conclusion that the fuel composition as claimed would have been obvious to one of ordinary skill in the art..." Neste declined to appeal this ruling and on July 31, 2012, the USPTO issued a Reexamination Certificate canceling all claims of the '018 patent. Likewise, the related '344 patent is the subject of an inter partes reexamination wherein the USPTO issued a September 14, 2012 Office Action rejecting all claims of that patent as obvious in view of the prior art. This reexamination is pending and is assigned Reexam Control Number 95002084.

Syntroleum is currently defending Neste's suit filed May 29, 2012 on the '344 patent in the District of Delaware. Syntroleum's Answer and Counterclaims to Neste's First Amended Complaint regarding the '344 patent was filed on September 24, 2012, and Syntroleum's Motion to Stay the district court action in view of the USPTO reexamination proceedings is pending. Syntroleum will pursue its non-infringement, invalidity and other defenses with respect to both asserted Neste patents and is confident that its position will be vindicated.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs